BGPT: Author Review: Caroline Petitdemange

Explore by Goal

Quick Explanation Copied

Caroline Petitdemange — scientific profile (from provided publication list + citation metrics)

Published work centers on innate immunity / NK cells across arboviral infections (CHIKV, DENV) and viral persistence / lentiviral models, with themes spanning NK repertoire, polarization, and immunopathology.
Evidence quality can’t be judged from metadata alone, but the presence of multiple peer-reviewed experimental articles (plus reviews) in immunology/virology is consistent with an active research program.
Main scientific gap in this prompt: the actual methods/results of the cited works are not provided, so rigor/reproducibility can’t be directly audited here.

Long Explanation

Author Review (Science Strength): Caroline Petitdemange

Scope limitation (critical): You provided only a paper list + OpenAlex-style aggregate metrics. No full-text experimental results are included in the prompt, so I can evaluate topic coherence, likely evidence types (article vs review), and publication footprint—but I cannot rigorously audit experimental rigor, bias controls, sample sizes, or statistical methods from this input alone.

1) Research focus map (from provided works)

NK-cell repertoire & polarization in acute infection contexts (e.g., CHIKV)
Comparative innate immune dynamics across CHIKV vs DENV and co-infection scenarios (longitudinal NK profiling).
Viral persistence / tissue-resident innate control in primate models where NK activity intersects with interferon pathways.
NK-cell biology across lentiviral/SIV settings (including MHC-E restricted activity in lymph nodes).
Immunopathology-focused synthesis where NK and innate immune regulation are framed in the context of disease control vs pathology.

2) Citation footprint over time (from provided OpenAlex extract)

This chart uses the provided counts_by_year in your prompt (it is not independently verified here).

3) Evidence-type mix: articles vs reviews (from provided works)

Critical note: “Review” status only indicates indexing type; it doesn’t reveal whether the review is qualitative, systematic, or quantitative, nor whether it prioritizes high-quality primary studies. To judge bias/reproducibility, full texts are needed.

4) Paper-centric critique (what can be inferred from DOIs + metadata)

4.1 Strength signals

Mechanism-aligned topics: Multiple indexed works connect NK-cell phenotypes to functional outcomes (e.g., cytotoxic polarization, MHC-E restricted activity, or control of persistence). Example: CHIKV NK polarization toward cytotoxicity .
Cross-disease comparators: Longitudinal NK comparisons across CHIKV vs DENV vs dual infections can reduce confounding that would arise in single-pathogen-only designs (but you must verify how groups were defined and statistically handled). .
Causal framing appears in higher-evidence settings: The SARS-CoV-2 persistence paper explicitly ties persistence control to IFN-γ and NK cells in a macaque model (which, if confirmed in methods, is closer to perturbation-based inference). .

4.2 Scientific blind spots / what this prompt cannot verify

No methods detail provided: I can’t inspect controls (e.g., gating strategies for NK subsets, batch effects, blinded analysis, or normalization procedures) for any specific study. Without that, rigor and reproducibility remain unknown.
Correlation vs causation unknown: Titles/abstract indexing suggests mechanism in some works, but causal strength depends on perturbations (knockout/neutralization/depletion), replication, and alternative explanations. For example, any “NK cell control” claims require checking depletion experiments, off-target effects, and timepoint alignment. .
Population heterogeneity not assessable: Human infection cohorts (CHIKV/DENV) can have confounding via prior exposures, demographics, disease stage, comorbidities, and treatment status. Without cohort tables and statistical model details, generalization strength is uncertain. .

5) Key referenced works (from your provided list)

Year	Topic	Type	DOI
2011	CHIKV NK repertoire & cytotoxic polarization	Article	10.1371/journal.ppat.1002268
2014	CHIKV & DENV control by NK (review)	Review	10.3389/fimmu.2014.00209
2015	CHIKV immunopathology control (review)	Review	10.1016/j.jaci.2015.01.039
2014	HLA/KIR genotypes and CHIKV/DENV type-2 (association)	Article	10.1371/journal.pone.0108798
2016	Longitudinal NK in DENV vs CHIKV (and co-infection)	Article	10.1371/journal.pntd.0004499
2019	Vaccine induction with antibodies + tissue-resident CD8+ T cells (SHIV)	Article	10.1172/jci.insight.126047
2021	SIV-induced adaptive NK (lymph nodes, MHC-E restricted)	Article	10.1038/s41467-021-21402-1
2023	IFN-γ & NK control SARS-CoV-2 persistence in macrophages	Article	10.1038/s41590-023-01661-4

6) Epistemic checks: what would most change my evaluation?

Internal validity evidence: If the key studies rely on weak controls (e.g., unblinded gating, insufficient batch correction, inadequate depletion specificity), then the mechanistic strength would drop substantially. (This is currently unknown because methods aren’t provided.)
Reproducibility: If follow-up studies fail to replicate NK polarization/repertoire signatures, then the claimed biological specificity would be less stable. (Again, cannot assess here.)
Alternative explanations: For human cohort comparisons, if confounders (prior exposure, disease stage, treatment) weren’t adequately modeled, then NK differences may reflect cohort composition rather than pathogen-specific immunobiology.

7) BGPT-style “scientific strength” verdict (based on provided information only)

Confidence level:

Moderate for topic coherence and publication footprint; low for experimental rigor and reproducibility, because full-text results and methods are not included in the prompt.

Feedback:

Updated: April 06, 2026